Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

Today, in Zug, Switzerland, on July 2, 2026, Oculis Holding AG, a global biopharmaceutical company concentrating on neuro-ophthalmic and ophthalmic disease solutions where medical needs remain unmet, disclosed their involvement at the Piper Sandler Virtual Ophthalmology Conference. The company's management team will partake in a fireside discussion at the event. Oculis is listed under the ticker symbols Nasdaq: OCS and XICE: OCS.